IXHL · Incannex Healthcare Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-11-14 | Widdows Peter |
Director |
Award↑
Filing footnotes — Common Stock, $0.0001 par value per share (Direct)
Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027. |
Common Stock, $0.0001 par value per share
|
1,686,956 |
| 2025-11-14 | Latham Joel |
Director, CEO and President |
Award↑
Filing footnotes — Common Stock, $0.0001 par value per share (Direct)
Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 5,652,173 Shares that vest in full on December 10, 2025, (ii) 5,652,173 Shares that vest in full on June 30, 2026, (iii) 5,652,173 Shares that vest in full on June 30, 2026 and (iv) 5,652,173 Shares that vest in full on June 30, 2027. |
Common Stock, $0.0001 par value per share
|
22,608,692 |
| 2025-11-14 | Anastassov George |
Director |
Award↑
Filing footnotes — Common Stock, $0.0001 par value per share (Direct)
Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027. |
Common Stock, $0.0001 par value per share
|
1,686,956 |
| 2025-11-14 | Swan Joseph |
CFO, Treasurer and Secretary |
Award↑
Filing footnotes — Common Stock, $0.0001 par value per share (Direct)
Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 289,855 Shares that vest on December 10, 2025, (ii) 289,855 Shares that vest on June 30, 2026; and (iii) 289,855 Shares that vest on June 30, 2027. |
Common Stock, $0.0001 par value per share
|
869,565 |
| 2025-11-14 | Valentine Troy |
Director |
Award↑
Filing footnotes — Common Stock, $0.0001 par value per share (Direct)
Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 2,825,652 Shares that vest in full on December 10, 2025, (ii) 2,825,652 Shares that vest in full on June 30, 2026, (iii) 2,825,652 Shares that vest in full on June 30, 2026 and (iv) 2,825,652 Shares that vest in full on June 30, 2027. |
Common Stock, $0.0001 par value per share
|
11,302,608 |
| 2025-11-14 | Clark Robert |
Director |
Award↑
Filing footnotes — Common Stock, $0.0001 par value per share (Direct)
Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027. |
Common Stock, $0.0001 par value per share
|
1,686,956 |
| 2024-10-23 | Barbato Luigi M. |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after October 21, 2024 and at the end of every twelve-month period thereafter over the remaining 24 months, subject to continued service for the Issuer on each vesting date. |
Common Stock
|
100,476 |
| 2024-10-21 | Barbato Luigi M. |
Chief Medical Officer |
Other↑
|
No Securities Owned
|
0 |
| 2023-12-21 | Latham Joel |
Director, CEO and President |
Award↑
Filing footnotes — Common Stock (Direct)
Award of restricted stock of which 335,000 shares will vest on December 31, 2023, 335,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 335,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 335,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing employment on each vesting date. |
Common Stock
|
1,340,000 |
| 2023-12-21 | Valentine Troy |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Award of restricted stock of which 167,500 shares will vest on December 31, 2023, 167,500 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 167,500 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 167,500 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date. |
Common Stock
|
670,000 |
| 2023-12-21 | Anastassov George |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date. |
Common Stock
|
100,000 |
| 2023-12-21 | Widdows Peter |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date. |
Common Stock
|
100,000 |
| 2023-12-21 | Clark Robert |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date. |
Common Stock
|
100,000 |
| 2023-11-28 | Bhalla Madhukar |
Secretary and CFO |
Other↑
|
No Securities Owned
|
0 |